Radopep-GM
Composition: Glibenclamide 5 mg, Pioglitazone 15 mg and Metformin Hydrochloride 500 mg
Radopep GM is the combination of Glibenclamide 5 mg, Pioglitazone 15 mg, and Metformin Hydrochloride 500 mg is a triple therapy medication used to treat type 2 diabetes.
Glibenclamide 5 mg
Class: Second-generation sulfonylurea
Function: Stimulates the release of insulin from the pancreas.
Pioglitazone 15 mg
Class: Thiazolidinedione (TZD)
Function: Improves insulin sensitivity in the body's tissues.
Metformin Hydrochloride 500 mg
Class: Biguanide
Function: Reduces glucose production in the liver and improves insulin sensitivity.
Combined Uses:
Lower blood sugar levels: Helps control blood sugar levels in people with type 2 diabetes.
Reduce the need for insulin: May reduce the need for insulin injections in some patients.
Improve blood lipid profile: May help lower cholesterol and triglyceride levels.
Strip: 10x10 tablets